Recursion Pharmaceuticals (NASDAQ:RXRX) is set to give its latest quarterly earnings report on Wednesday, 2026-02-25. Here’s what investors need to know before the announcement.
Analysts estimate that Recursion Pharmaceuticals will report an earnings per share (EPS) of $-0.30.
Investors in Recursion Pharmaceuticals are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It’s worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Past Earnings Performance
Last quarter the company beat EPS by $0.02, which was followed by a 6.85% drop in the share price the …